Timothy Sullivan - Jan 29, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/s David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol
APLS
Transactions as of
Jan 29, 2024
Transactions value $
-$58,109
Form type
4
Date filed
1/31/2024, 04:34 PM
Previous filing
Jan 23, 2024
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$58.1K -906 -0.95% $64.14 94.8K Jan 29, 2024 Direct F1
holding APLS Common Stock 56.2K Jan 29, 2024 The Timothy E Sullivan Irrevocable Trust of 2023 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/26/2024.
F2 The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.